Countries dependent on Chinese vaccines are witnessing a surge in COVID-19 cases.

Chinese vaccines have comparatively less efficacy as the number of COVID-19 cases is on the rise in counties dependent solely on these vaccines.

Chinese vaccines have comparatively less efficacy as the number of COVID-19 cases is on the rise in counties dependent solely on these vaccines.Chinese vaccine makers Sinopharm and Sinovac have claimed that their vaccines can prevent severe COVID-19 cases. China has supplied its vaccines to many countries to help them battle the spread of the virus. But those vaccines were rolled out even before the final trials were conducted and before publishing the clinical data. The efficacy of Sinovac is just about 51 percent which is only one percent more than the threshold suggested by WHO. In contrast, western vaccines like Pfizer-BioNTech and Moderna have demonstrated efficacy rates of more than 90 percent.

Around 90 countries are using Chinese vaccines, and some have inoculated more than 50 percent of their population. Mongolia, Seychelles, Chile, and Bahrain have been using Chinese-made shots, but recent examples suggest that the Chinese vaccines are not effective in controlling the spread of the virus. New outbreaks have been reported in those countries, which have raised the question of vaccine's usefulness as new virus variants have emerged. According to scientists, it should not have happened as most of the population has been inoculated in those countries. They say that the low efficacy of Chinese shots may have caused recent outbreaks.